Luftner D, Schuetz F, Schneeweiss A, Hartkopf A, et al. Efficacy and safety of everolimus plus exemestane in patients with hormone receptor-positive, HER-2-negative advanced breast cancer: Results from the open-label, multicentre, non-interventional BRAWO study. Int J Cancer 2024 Mar 6. doi: 10.1002/ijc.34912.
PMID: 38447007